Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4822759 | 0.75 | NOS2 (0.44) | PARP1 | |
| SCHEMBL4819933 | 0.70 | ADRA1A (0.46) | PARP1 | |
| SCHEMBL4826835 | 0.69 | PARP1 (0.35) | PARP1 | |
| SCHEMBL4825996 | 0.69 | PARP1 (0.39) | PARP1 | |
| Hydrochloric Acid SCHEMBL4825596 | 0.67 | PARP1 (0.34) | PARP1 | |
| SCHEMBL29593942 | 0.67 | HTR2A (0.52) | — | |
| SCHEMBL714536 | 0.67 | HTR2A (0.52) | — | |
| Hydrochloric Acid SCHEMBL1571970 | 0.65 | IDO1 (0.55) | — | |
| SCHEMBL2840159 | 0.63 | CD44 (0.43) | — | |
| SCHEMBL5157368 | 0.62 | CD44 (0.36) | PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7396369-B2 | 2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers | L'OREAL S.A. (FR) | 2008-07-08 | — | — | US | claimed |
| US-20070011823-A1 | Novel 2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers | L'OREAL S.A. (FR) | 2007-01-18 | — | — | US | claimed |
| EP-1739073-A1 | New primary 2,3-disubstituted para-phenylendiamins and their use as oxidative colouring of keratinic fibers | L'Oréal (FR) | 2007-01-03 | — | — | EP | claimed |
| US-7396369-B2 | 2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers | L'OREAL S.A. (FR) | 2008-07-08 | — | — | US | disclosed |
| US-7396369-B2 | 2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers | L'OREAL S.A. (FR) | 2008-07-08 | — | — | US | disclosed |
| US-7396369-B2 | 2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers | L'OREAL S.A. (FR) | 2008-07-08 | — | — | US | disclosed |
| US-20070011823-A1 | Novel 2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers | L'OREAL S.A. (FR) | 2007-01-18 | — | — | US | disclosed |
| US-20070011823-A1 | Novel 2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers | L'OREAL S.A. (FR) | 2007-01-18 | — | — | US | disclosed |
| US-20070011823-A1 | Novel 2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers | L'OREAL S.A. (FR) | 2007-01-18 | — | — | US | disclosed |
| EP-1739073-A1 | New primary 2,3-disubstituted para-phenylendiamins and their use as oxidative colouring of keratinic fibers | L'Oréal (FR) | 2007-01-03 | — | — | EP | disclosed |
| EP-1739073-A1 | New primary 2,3-disubstituted para-phenylendiamins and their use as oxidative colouring of keratinic fibers | L'Oréal (FR) | 2007-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070011823-A1 | Novel 2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers | KRT18, VIM, CDC73 | BPTF 2663/4885PARP1 560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.